The International Court in Tehran ordered its foe the United States to pay $6.785 billion to patients with epidermolysis bullosa, a disorder that causes the skin to blister easily, the judiciary's Mizan Online website said on Thursday.
Commissioner Food Safety and Drug Administration Department Dr R Rajesh Kumar said that the lab is also likely to get recognition from the National Testing and Calibration Accreditation Board (NABL) soon. After this, the lab testing report will be valid all over the world.
Well-placed industry sources told ET HealthWorld that the PIL filed at the Delhi High Court raises objections against the government’s lax regulatory framework to assess the quality, safety and efficacy of imported second-hand or used medical devices. The petition, moved recently, has called for a comprehensive review of the regulations for refurbished medical devices that may compromise the safety of the patients.
The centre will showcase ICU beds, emergency transport ambulance cots, surgeon stools and automated external defibrillators (AEDs), and other medical products. It will enable healthcare professionals to experience firsthand the capabilities of the company's offerings through personalised demonstrations and provide valuable feedback to Stryker’s R&D team.
First-quarter earnings at Gerresheimer's primary packaging glass division, which makes vials, fell 14.5% versus last year to reach 34.8 million euros. But earnings at its plastics and devices division, which makes syringes and injector pens, jumped 26.5% to 59.3 million euros.
According to information from sources cited by TOI, the recent Central Bureau of Investigation (CBI) operation at Ram Manohar Lohia Hospital was launched following technical surveillance starting from March. Furthermore, it is said that the CBI utilized decoy patients to confirm the intelligence they had collected before taking action.
Its earnings before interest, tax and amortisation (EBITA), adjusted for items affecting comparability, were 842 million Swedish crowns ($77 million), down 13.4% from 972 million a year earlier, but above a consensus of 770 million cited by J.P.Morgan.
Earlier, CSIR-Neeri director Atul Vaidya outlined the genesis of the institute. He said the institute has positioned itself to address the challenges posed by environmental issues. He described various parameters on which CSIR-Neeri is performing well, including technological developments and planning aligned with the vision for 2047 to ensure sustainable development.
Correct information regarding the ground reality must be presented before the Delhi High Court, which stated on Wednesday that it wished to "assist" the city government in improving the state of its hospitals rather than engage in a "blame game."
On Monday, the Delhi High Court ordered the city government to verify that every piece of medical equipment in its hospitals is operational and to provide an explanation for the "apparent" decline in hospital spending. The court also observed that the Delhi government's affidavit said that the "budget expenditure" for its hospitals decreased from approximately Rs 3,500 crore in 2022–2023 to approximately Rs 2,800 crore in 2023–2024.
However, its net sales of $747.4 million in the quarter missed LSEG estimates of $750.31 million. The company's sales have taken a hit in recent quarters from falling demand for products used in COVID-19 vaccines and therapies. Demand for COVID products has dropped significantly in the past year, leading drugmaker Pfizer to slash its full-year revenue forecast by 13 per cent this month and announce a $3.5 billion cost-cut program.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
